201. アンジェルマン症候群 Angelman syndrome Clinical trials / Disease details


臨床試験数 : 24 薬物数 : 35 - (DrugBank : 9) / 標的遺伝子数 : 22 - 標的パスウェイ数 : 20

  
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02056665
(ClinicalTrials.gov)
January 20145/2/2014Study to Evaluate the Efficacy and Safety of Minocycline in Angelman SyndromeRandomized Clinical Trial, Placebo Compared to Evaluate the Efficacy and Safety of Minocycline in Angelman SyndromeAngelman SyndromeDrug: MINOCYCLINE;Drug: PLACEBO (for Minocycline)Puerta de Hierro University HospitalNULLCompleted6 Years30 YearsBoth32Phase 2Spain
2EUCTR2013-002154-67-ES
(EUCTR)
26/12/201316/09/2013STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MINOCYCLINE IN ANGELMAN SYNDROME (A-MANECE STUDY)RANDOMIZED CLINICAL TRIAL, PLACEBO COMPARED TO EVALUATE THE EFFICACY AND SAFETY OF MINOCYCLINE IN ANGELMAN SYNDROME (A-MANECE STUDY) - A-MANECE Angelman Syndrome
MedDRA version: 16.0;Level: PT;Classification code 10049004;Term: Angelman's syndrome;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Trade Name: Aknemin 50
INN or Proposed INN: MINOCYCLINE
Other descriptive name: MINOCYCLINE HYDROCHLORIDE
Dra. Cristina Avendaño SoláNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Spain
3NCT01531582
(ClinicalTrials.gov)
April 20125/2/2012Minocycline in the Treatment of Angelman SyndromeThe Efficacy of Minocycline in the Treatment of Angelman SyndromeAngelman SyndromeDrug: minocyclineUniversity of South FloridaNULLActive, not recruiting4 Years12 YearsBoth25N/AUnited States